Culturally Aware AET Non-Initiation Intervention (NCT05465408) | Clinical Trial Compass
CompletedNot Applicable
Culturally Aware AET Non-Initiation Intervention
United States35 participantsStarted 2022-07-21
Plain-language summary
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female
* Age 21 or older
* Diagnosis of early-stage (Stage I-IIIB), hormone receptor-positive breast cancer
* Recommended to start AET at least 3 weeks prior and not currently taking AET OR recommended to start AET in the future, and reports hesitations to start AET as determined by a score of \>/= 4 (range =0-10) when asked "How hesitant are you about starting your recommended hormonal therapy? (0=Not at all hesitant and 10 = Extremely hesitant)"
* Ability to read and respond in English or Spanish
* Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
* For at least 10 participants, identify as a member of a racial or ethnic minority community per self-report
Exclusion Criteria:
* Uncontrolled psychosis, active suicidal ideation, psychiatric hospitalization within the past year
* Cognitive impairment that prohibits participation in the study
* Undergoing primary treatment for another cancer (i.e., advanced-stage cancer)
* Participating in a clinical trial involving AET